Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04868500 · ClinicalTrials.gov registry record · NA
Managing Asthma Patients With AMAZE™: A Novel Disease Management Platform
A NA study, sponsored by AstraZeneca.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT04868500 is a NA study that has completed, run by AstraZeneca. The registered enrollment target is 49 participants.
The verdict
NCT04868500, a NA study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
The primary study objective is to generate evidence as to the feasibility, usability, perceived value, and potential benefits of implementing the AMAZE™ platform into clinical practice.
Interventions
- DEVICE AMAZE™ Application
- DEVICE AMAZE™ Dashboard
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2021-04-27 |
| Est. Completion | 2021-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04868500
The ClinicalTrials.gov registry entry for NCT04868500 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AMAZE™ Application is the first listed.
NCT04868500 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04868500 about?
NCT04868500 is a clinical study titled "Managing Asthma Patients With AMAZE™: A Novel Disease Management Platform". The primary study objective is to generate evidence as to the feasibility, usability, perceived value, and potential benefits of implementing the AMAZE™ platform into clinical practice.
What is the current status of trial NCT04868500?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2021-04-27. Estimated completion is 2021-11-30.
What interventions are being tested in trial NCT04868500?
The interventions under investigation include: AMAZE™ Application (DEVICE), AMAZE™ Dashboard (DEVICE).
Who is sponsoring clinical trial NCT04868500?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.